...
首页> 外文期刊>International journal of infectious diseases : >Enhanced Patient Serum Immunoreactivity to Recombinant Mycobacterium tuberculosis CFP32 Produced in the Yeast Pichia Pastoris Compared to Escherichia coli and Its Potential for Serodiagnosis of Tuberculosis
【24h】

Enhanced Patient Serum Immunoreactivity to Recombinant Mycobacterium tuberculosis CFP32 Produced in the Yeast Pichia Pastoris Compared to Escherichia coli and Its Potential for Serodiagnosis of Tuberculosis

机译:与大肠杆菌相比,提高了对酵母巴斯德毕赤酵母中产生的重组结核分枝杆菌CFP32的患者血清免疫反应性及其对结核病的血清诊断的潜力

获取原文

摘要

CFP32 is a Mycobacterium tuberculosis complex-restricted secreted protein that was previously reported to be present in a majority of sputum samples from patients with active tuberculosis (TB) and to stimulate serum antibody production. CFP32 (annotated as Rv0577) was therefore considered a good candidate target antigen for the rapid serodiagnosis of TB. However, the maximal sensitivity of CFP32 serorecognition may have been limited in earlier studies because recombinant CFP32 (rCFP32) produced in Escherichia coli was used as the test antibody-capture antigen, a potential shortcoming stemming from differences in bacterial protein posttranslational modifications.
机译:CFP32是结核分枝杆菌复合物限制的分泌蛋白,以前被报道存在于患有活动性结核病(TB)患者的大部分痰液样本中,并刺激血清抗体产生。因此,CFP32(注解为Rv0577)被认为是结核病快速血清诊断的良好候选靶抗原。但是,CFP32血清识别的最大敏感性可能在早期的研究中受到了限制,因为在大肠杆菌中产生的重组CFP32(rCFP32)被用作测试抗体捕获抗原,这可能是由于细菌蛋白翻译后修饰的差异而引起的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号